Caverflo.com is voluntarily recalling all lots of Caverflo Natural Herbal Coffee, 25 grams to the consumer level. FDA laboratory analysis confirmed the presence of Sildenafil and Tadalafil which are the active ingredients in two FDA-approved prescription drugs used for the treatment of erectile dysfunction (ED). Caverflo.com has received a report of an individual death after use of the coffee. Caverflo Natural Herbal Coffee may also contain undeclared milk.
Read The Complete Story!
Category Archives: Food Safety News
California Sun Dry Foods Announces a Voluntary Recall of Mislabeled California Sun Dry Sun-Dried Tomato Pesto Due to Undeclared Almond and Milk Allergen
California Sun Dry Foods today issued a voluntary recall of California Sun Dry Sun-Dried Tomato Pesto because of a potentially incorrect back label on some jars. This mislabeling incident resulted in undeclared allergens (Almonds and Milk). People who have an allergy or severe sensitivity to tree nuts and milk run the risk of serious or life-threatening allergic reaction if they consume this product.
Read The Complete Story!
California Sun Dry Foods Announces a Voluntary Recall of Mislabeled California Sun Dry Sun-Dried Tomato Pesto Due to Undeclared Almond and Milk Allergen
California Sun Dry Foods today issued a voluntary recall of California Sun Dry Sun-Dried Tomato Pesto because of a potentially incorrect back label on some jars. This mislabeling incident resulted in undeclared allergens (Almonds and Milk). People who have an allergy or severe sensitivity to tree nuts and milk run the risk of serious or life-threatening allergic reaction if they consume this product.
Read The Complete Story!
MusclMasster LLC Issues Voluntary Nationwide Recall of Al-Er-G Capsules Because it Contains the Banned Substance Ephedra
MusclMasster, LLC of Wheat Ridge, CO is recalling all bottles of Al-Er-G Capsules because they contain the presence of Ephedra Herb, an FDA banned ingredient. Dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events, including heart attack, stroke, and death, and that these risks are unreasonable in light of any benefits that may result from the use of these products under their labeled conditions of use.
Read The Complete Story!
FDA approves first cancer treatment for any solid tumor with a specific genetic feature
The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated
FDA approves first cancer treatment for any solid tumor with a specific genetic feature
The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated
FDA approves first drug to specifically treat giant cell arteritis
The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis.
FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis
The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis. The approval triples the number of rare gene mutations that the drug can now treat, expanding the indication from the treatment of 10 mutations, to 33. The agency based its decision, in part, on the results of laboratory testing, which it used in conjunction with evidence from earlier human clinical trials. The approach provides a pathway for adding additional, rare mutations of the disease, based on laboratory data.
FDA warns Americans about risk of inaccurate results from certain lead tests
The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in the United States.
La Nica Products, Inc. Recalls Cheese Because of Possible Health Risk
La Nica Products, Inc. of Miami, FL is recalling six thousand pounds of cheese, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, listeria infection can cause miscarriages and stillbirths among pregnant women.
Read The Complete Story!